EVALUATING TECHNOLOGICAL INFORMATION AND UTILIZING IT - SCIENTIFIC KNOWLEDGE, TECHNOLOGICAL CAPABILITY, AND EXTERNAL LINKAGES IN BIOTECHNOLOGY
EVALUATING TECHNOLOGICAL INFORMATION AND UTILIZING IT - SCIENTIFIC KNOWLEDGE, TECHNOLOGICAL CAPABILITY, AND EXTERNAL LINKAGES IN BIOTECHNOLOGY
复制标题
DOI：
10.1016/0167-2681(94)90055-8
复制
发表时间：
1994-06-01
影响因子：
2.2
通讯作者：
GAMBARDELLA, A
中科院分区：
文献类型：
--
作者：
ARORA, A;GAMBARDELLA, A
创新理论的最新研究表明，合作联盟在创新过程中的作用已经变得非常重要。在本文中，我们认为，企业从这些合作关系中受益的能力显着不同。我们与企业的内部知识基础的合作协议（外部联系），它进入与其他代理商（小型启动生物技术公司，大学）赋予创新的互补资产的数量。我们区分科学能力和技术能力，前者涉及信息的评估，后者涉及利用。我们测试的影响，该模型使用的样本上的26个大型美国化学和制药公司活跃在生物技术领域在20世纪80年代使用计量经济学技术计数事件。
Recent research in the theory of innovation has suggested that the role of collaborative alliances in the innovation process has become very important. In this paper we argue that firms differ significantly in their ability to benefit from these collaborative relationships. We relate the internal knowledge base of the firm to the number of collaborative agreements (external linkages) that it enters into with other agents (small start-up biotechnology firms, and universities) endowed with complementary assets for innovation. We distinguish between scientific and technological capabilities, the former relating to the evaluation of information, and the latter to the utilization. We test the implications of the model using data on a sample of 26 large U.S. chemical and pharmaceutical companies active in the biotechnology sector in the 1980s using econometric techniques appropriate for count events.